“Risk factors of doxorubicin-induced cardiomyopathy in non-muscle- invasive bladder cancer”, Univ Med, vol. 43, no. 3, pp. 297–303, Nov. 2024, doi: 10.18051/UnivMed.2024.v43.297-303.